Proteon logo     Print Page | Close Window

SEC Filings

S-3/A
PROTEON THERAPEUTICS INC filed this Form S-3/A on 08/14/2017
Entire Document
 
 

 

EXHIBIT INDEX

 

 

3.1   Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock, dated August 1, 2017 (incorporated by reference to Exhibit 3.1 of Current Report on Form 8-K, filed on August 3, 2017)
     
4.1   Fifth Amended and Restated Investors’ Rights Agreement, dated June 22, 2017, by and among Proteon Therapeutics, Inc. and the stockholders party thereto (incorporated by reference to Exhibit 4.18 of Current Report on Form 8-K, filed on June 23, 2017).
     
4.2   Registration Rights Agreement, dated as of August 2, 2017 (incorporated by reference to Exhibit 4.1 of Current Report on Form 8-K, filed on August 3, 2017).
     
5.1#   Opinion of Morgan, Lewis & Bockius LLP.
     
10.1   Securities Purchase Agreement, dated as of June 23, 2017, by and among the Company and the purchasers party thereto (incorporated by reference to Exhibit 10.20 of Current Report on Form 8-K, filed on June 23, 2017).
     
23.1*   Consent of Independent Registered Public Accounting Firm.
     
23.2#   Consent of Morgan, Lewis and Bockius LLP (included in Exhibit 5.1).

 

*      Filed herewith

#      Previously filed